این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Basic and Clinical Cancer Research، جلد ۹، شماره ۳، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Iran Cancer Statistics in 2012 and projection of cancer incidence by 2035
چکیده انگلیسی مقاله Background; Near future will be the most challenging time of non-communicable diseases, especially cancers in developing countries including Iran. Convincing stakeholders, allocating resources, and providing infrastructures for cancer prevention, diagnosis, treatment, and palliative care require valid and reliable information and statistics. Methods; Every four years, International Agency on Cancer Research (IARC) releases GLOBOCAN data which is estimation of incidence, mortality, and prevalence of cancer using IARC members' data. We present estimation of the incidence, mortality, and prevalence of cancer in Iran in 2012, and also the trend line of cancer between 2008 and 2012, derived from "GLOBOCAN 2008 and 2012". Results; A total number of 84829 of all cancers excl. non-melanoma skin cancers, age adjusted incidence rate (ASR) was 127.7 per 100000 for Iran in 2012; the ratio of ASRs of incidence rate between men (134.7 per 100000) and women (120.1 per 100000) was 1.12. Totally, 9795 cases of breast cancer (28.1 per 100000), 9660 cases of stomach cancer (15.3 per 100000), 7163 cases of colorectal cancer (11.1 per 100000), 5343 cases of esophageal cancer (8.6 per 100000), and 5343 cases of bladder cancer (8.4 per 100000) diagnosed in both sexes in 2012. Ten most commonly diagnosed cancers among women, in 2012 were cancers of breast 9795 (28.1 per 100000), colorectal 3352 (10.5 per 100000), stomach 3020 (9.7 per 100000), esophagus 2445 (8 per 100000), and ovary 1637 (4.8 per 100000). The common cancers among men were cancers of stomach 6640 (20.6 per 100000), bladder 4277 (13.2 per 100000), prostate 4111 (12.6 per 100000), colorectal 3811 (11.6 per 100000), and lung 3307 (10.3 per 100000). Comparing the ASRs of Iran reported in GLOBOCAN 2008 vs. 2012 has shown a slight raise (5.25%; 107.3 per 100000 vs. 127.7 per 100000) during the period of time, which is not significant. In 2035, a total number of 184481 cancer new cases (97655 Males and 86826 Females) will occur in Iran, anticipating about 54% increase of cancer incidence in Iran during the next 23 years. Estimating the projection of the five most incident cancers in Iran was indicated increasing number of new cases in 2035 to 49.32% for breast cancer, 50.13% for ovary cancer, 55.96% for colorectal cancer, 58.21% for lung cancer, 58.42% for bladder cancer, 59.1% for stomach cancer, and 59.69% for esophageal cancer. Conclusions; Although GLOBOCAN provide countries with cancer statistics, lack of population-based cancer registry and cancer surveillance system in most countries like Iran make monitoring and improving health delivery system rigorous. About 50% increase in the number of new cancer cases by 2035 should aware stakeholders to allocate more resources to cancer surveillance system and be more focused on cancer control program.
کلیدواژه‌های انگلیسی مقاله Neoplasm, Iran, Prevalence, Incidence, Mortality, GLOBOCAN
نویسندگان مقاله الهام محبی | elham mohebbi
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

آذین نحوی جو | azin nahvijou
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

مریم حاجی | maryam hadji
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

حمیده رشیدیان | hamideh rashidian
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

منیره سادات سیدصالحی | monireh sadat seyyedsalehi
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

سعید نعمتی | saeed nemati
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

محمدرضا روح اللهی | mohammad reza rouhollahi
cancer research center, iran cancer institute, tehran university of medical sciences, tehran, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

کاظم زنده دل | kazem zendehdel


نشانی اینترنتی http://bccr.tums.ac.ir/index.php/bccrj/article/view/270
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات